Immediate Impact

2 by Nobel laureates 4 from Science/Nature 54 standout
Sub-graph 1 of 23

Citing Papers

Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes
2025 Standout
Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial
2024 Standout
2 intermediate papers

Works of Tim Bauer being referenced

Exenatide improves diastolic function and attenuates arterial stiffness but does not alter exercise capacity in individuals with type 2 diabetes
2016

Author Peers

Author Last Decade Papers Cites
Tim Bauer 109 66 91 161 144 11 573
Wan-Jung Tsai 89 19 41 152 92 21 570
Alen Jambrecina 31 43 85 66 40 6 508
Hiroshi Kawamata 38 35 110 139 33 15 482
Gaurav Singh 40 20 44 140 296 14 615
Fen Yuan 83 14 88 232 91 19 630
Ovidiu Frățilă 32 30 126 166 58 32 621
Min Cheol Kim 39 20 77 164 136 34 564
Kald Beshir Tuem 25 25 29 116 43 13 576
Song-Chow Lin 32 22 68 175 87 22 602
Kung‐Chang Hwang 27 8 64 73 136 22 562

All Works

Loading papers...

Rankless by CCL
2026